Further, metformin has increased cardiac SOD activity in a model of T2DM genetically modified mice, an effect attributed to its antioxidant free radical scavenging ability [31], and sitagliptin was also shown to increase SOD activity [27]. The gene discussed is SOD1; the disease is type 2 diabetes mellitus.